[Sponsored] Greenway Health blends smart technology with human expertise to elevate revenue cycle. The post RCM Outsourcing: Balancing Human Expertise & Smart Technology appeared first on MedCity News.
If Legislature adopts proposal, Massachusetts would join California, Oregon and Rhode Island in setting spending targets
Shirley Ryan AbilityLab Earns New Joint Commission Sustainability Award With support from Compass One Healthcare, Shirley Ryan AbilityLab has reached another milestone in its commitment to environmental stewardship. The Chicago-based rehabilitation hospital, renowned for treating patients with stroke, spinal cord, and brain injuries, has earned The Joint Commission’s new Sustainability Healthcare Certification. It is the…
The federal government has drastically scaled back the number of recommended childhood immunizations, sidelining six routine vaccines that have safeguarded millions from serious diseases, long-term disability, and death. Just three of the six immunizations the Centers for Disease Control and Prevention says it will no longer routinely recommend — against hepatitis A, hepatitis B, and…
March has seen a slew of executive hires, exits and layoffs across the healthcare industry. For example, providers like Providence and Geisinger have appointed new C-suite leaders, and companies like Blue Shield of California and Evernorth have undergone CEO exits. There were also layoffs at organizations including HHS, Blue Cross of Idaho and the University…
Six days after a senior FDA official sent a sweeping internal email claiming that covid vaccines had caused the deaths of “at least 10 children,” 12 former FDA commissioners released an extraordinary warning in the Dec. 3 issue of the New England Journal of Medicine. They wrote that the claims and policy changes in the…
Blood centers are neutral partners, as they do not compete with hospitals for patients. Instead, they complement hospitals by providing a focused array of high-quality, specialized, patient-centric services, allowing hospitals to maintain primary relationships with patients and their families. The post Blood Centers Complement Hospitals to Drive Cell and Gene Therapy Access appeared first on…
This is one of the fundamental questions in health policy in recent years. Quality can be measured in two parts. First, does quality improved for targeted patients? Second, does quality improve for non-targeted patients. The first question is relatively clear. One would think that quality would improve for the patients targeted by a pay-for-performance (P4P)…
With staffing shortages, historic burnout, and rising costs, concierge medicine — and direct primary care (DPC) — have moved from the margins into the middle of the retention conversation. The post From Executive Perk to Employee Retention Strategy: Why Concierge Medicine and/or Direct Primary Care Is Now a Business Essential appeared first on MedCity News.
That is according to the FDA. Nature Reviews Drug Discovery summarizes the progress to date as follows. The FDA’s Center for Drug Evaluation and Research (CDER) and Center for Biologics Evaluation and Research (CBER) approved 57 new therapeutic drugs (NTD) in 2024. This is slightly above the average of 53 NTDs per year for 2014–2024,…